Home/Stocks/Financials

Bridgepoint Group PLC

BPTB.L·Financials·Market Cap £3.6b
Rank #176 of 280
Quantitative Model · 280 Stocks Analysed
£4.02
+41.58% YTD
52W: £2.12 - £4.03

Factor Analysis Summary

Editorial assessment generated from Bridgepoint Group PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Bridgepoint Group PLC (BPTB.L) currently holds an overall rank of #176 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit, and market trading, where it demonstrates healthy trading activity and market interest relative to the FTSE 100 median.

Areas requiring attention include asset efficiency, where poor capital efficiency suggests assets may be underutilised or overvalued on the balance sheet, as well as valuation (P/E 135.4, dividend yield 542.5%), where the stock appears richly priced on forward earnings and cash flow metrics.

Within the Financials sector, Bridgepoint Group PLC sits at composite rank #176, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

The composite profile is weighed down by 4 below-average factor scores, with asset efficiency (rank 273/280) representing the most significant drag on its #176 overall standing.

Strongest Factors

  • Liquidity — Rank 69/280 (top quartile)
  • Market Trading — Rank 87/280 (above average)
  • Technical — Rank 126/280 (middle of the pack)

Weakest Factors

  • Asset Efficiency — Rank 273/280 (below average)
  • Valuation — Rank 236/280 (below average)

Score Analysis

Bridgepoint Group PLC is ranked #176 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

173/280
Average Score
Liquidity
Excellent69/280
Valuation
Weak236/280
Profitability
Weak227/280
Solvency
Weak195/280
Asset Efficiency
Weak273/280
Mkt Trading
Good87/280
Technical
Fair126/280

1. Liquidity

Score: 69/280

How liquid is BPTB and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current Ratio7.22x
Range: N/ARank 20/280
–
TTM Operating Cash Flow0.07x
Range: N/ARank 209/280
–
Liquidity Coverage RatioN/A
Range: 100-150
✗
Intangible Asset Ratio0.04x
Range: 10 - 30Rank 94/280
–
Cash-to-Debt Ratio0.11x
Range: N/ARank 197/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
7.22x
Sector: N/A

Overall Liquidity Rank

Rank within universe#69/280
Best (1)Worst (280)

2. Valuation

Score: 236/280

Is BPTB undervalued compared to its peers and fair value metrics?

3/7
valuation criteria met
✓
FY27e P/E13.2x
Range: 8x - 18xRank 139/280
✓
FY26e P/E12.7x
Range: 8x - 18xRank 99/280
✓
FY27e Net Div Yld (%)3.12%
Range: 3.0 - 8.0Rank 130/280
✗
Div Payout Ratio316.01%
Range: 30 - 55Rank 25/280
–
Current EV/EBITDA16.4x
Range: N/ARank 232/280
✗
Current P/TBV8.51x
Range: 0.8x - 2.0xRank 196/280
✗
Current P/B2.42x
Range: 0.8x - 2.0xRank 186/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
135.4x
FY26e P/E
Forward estimate
12.7x
FY27e P/E
Forward estimate
13.2x
Current P/B
Price-to-Book
2.42x
Current P/TBV
Tangible Book Value
8.51x
Current EV/EBITDA
Enterprise Value
16.4x
FY26e EV/EBITDA
Forward estimate
13.6x
FY27e EV/EBITDA
Forward estimate
N/A

Dividend

BPTB pays a dividend yield of 542.53%.

Current Yield
542.53%
FY27e Net Div Yield
3.12%
FY26e Gross DPS
0.116
FY27e Gross DPS
0.125

Dividend Per Share Forecast

3. Profitability

Score: 227/280

How profitable is BPTB relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin5.4%
Range: 15 - 30Rank 191/280
–
T12 FCF Margin0.0%
Range: N/ARank 192/280
✗
FY27e RoE25.5%
Range: 10 - 16Rank 55/280
✗
FY26 EPS Growth22.5%
Range: 8 - 15Rank 53/280
✗
FY27e EPS Growth17.7%
Range: 6 - 12Rank 123/280
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
5.4%
Current RoCE
4.2%
FY27e RoE
25.5%
T12 FCF Margin
0.0%

EPS Growth

4. Solvency

Score: 195/280

How strong is BPTB's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt2.66x
Range: 0.5x - 1.5xRank 246/280
–
Interest Coverage RatioRank 144
Range: N/ARank 144/280
–
Net Leverage Ratio1.33x
Range: N/ARank 95/280
–
Altman Z-Score (Manufacturing)5.04
Range: N/ARank 124/280
–
Z-Score (Non Manufacturing)Rank 214
Range: N/ARank 214/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
2.66x
Net Leverage Ratio
1.33x
Interest Coverage
Rank 144
T12 FCF Margin
0.0%

Altman Z-Score

5.04
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 273/280

How efficiently does BPTB deploy its assets and intellectual capital?

1/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.15x
Range: N/ARank 202/280
✓
TTM CAPEX/Sales1.1%
Range: 1 - 3Rank 174/280
–
Working Capital Turnover0.27x
Range: N/ARank 159/280
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#273/280
Best (1)Worst (280)

6. Market Trading

Score: 87/280

How liquid and actively traded is BPTB?

1/2
market trading criteria met
✗
Intraday Sentiment (%)86.0%
Range: 40 - 75Rank 33/280
–
10D-Avg v/s 3M-Avg Vol146%
Range: N/ARank 50/280
✓
Avg Directional Index 30D28.0
Range: 012 - 45Rank 49/280
–
Parabolic SAR331.79
Range: N/ARank 191/280
–
Stock Rating RankRank 50
Range: N/ARank 50/280
Market Cap
£3,621,759,350
Enterprise Value
£6,900,476,132

Trading Volume

7. Technical

Score: 126/280

What do the technical indicators say about BPTB?

0/5
technical criteria met
–
CMP v/s 52-WH-0.2%
£4.03£2.12
-0.2%CMP: £4.02
Range: N/ARank 2/280
–
CMP v/s 52-WL89.5%
£4.03£2.12
+89.5%CMP: £4.02
Range: N/ARank 265/280
–
RSI 14D86.5
086.5 - Overbought100
Range: N/ARank 25/280
–
MA50 - MA200Bullish
£2.79+0.44£3.23
Range: N/ARank 83/280
–
MACD Rank9.20
Golden Cross
MACD: 9.20
Range: N/ARank 100/280

RSI (14 Day)

86.5
Overbought
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£3.23
200 SMA£2.79
SignalGolden Cross (Bullish)
MACD9.20

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does BPTB compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
BPTB#1766923622719587126
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Bridgepoint Group PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.